ATM and neoplasm: Among the 30 patients with tumors evaluated for ATM immunohistochemical (IHC) analysis, two-thirds of samples (20/30) displayed loss of protein expression, whereas 33% (10/30) had varying levels of tumor cell ATM protein expression (median H-score 95; IQR 46–190) (Extended Data Fig. 4b).